Elevated expression of the interleukin 4 receptor in carcinoma: a target for immunotherapy?

Studies using monoclonal antibody MR6, which is thought to bind to the interleukin-4 growth factor receptor (IL-4R), indicate that IL-4R molecules are upregulated in tumours of epithelial origin and that radiolabelled MR6 is effective as an in vivo tumour imaging agent. Immunohistochemical analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Jabaari, B., Ladyman, H. M., Larché, M., Sivolapenko, G. B., Epenetos, A. A., Ritter, M. A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1989
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246718/
https://www.ncbi.nlm.nih.gov/pubmed/2736228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246718/
https://www.ncbi.nlm.nih.gov/pubmed/2736228

Ejemplares similares